Kream BE - Search Results

1

Selective osteoblast overexpression of IGF-I in mice prevents low protein-induced deterioration of bone strength and material level properties.

Brennan-Speranza TC, Rizzoli R, Kream BE, Rosen C, Ammann P. Brennan-Speranza TC, et al. Among authors: kream be. Bone. 2011 Nov;49(5):1073-9. doi: 10.1016/j.bone.2011.07.039. Epub 2011 Aug 5. Bone. 2011. PMID: 21840432

2

Postnatal growth and bone mass in mice with IGF-I haploinsufficiency.

He J, Rosen CJ, Adams DJ, Kream BE. He J, et al. Among authors: kream be. Bone. 2006 Jun;38(6):826-35. doi: 10.1016/j.bone.2005.11.021. Epub 2006 Jan 19. Bone. 2006. PMID: 16427371

3

Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling.

Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE. Jiang J, et al. Among authors: kream be. Bone. 2006 Sep;39(3):494-504. doi: 10.1016/j.bone.2006.02.068. Epub 2006 Apr 27. Bone. 2006. PMID: 16644298

4

Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshop.

Khosla S, Bellido TM, Drezner MK, Gordon CM, Harris TB, Kiel DP, Kream BE, LeBoff MS, Lian JB, Peterson CA, Rosen CJ, Williams JP, Winer KK, Sherman SS. Khosla S, et al. Among authors: kream be. J Bone Miner Res. 2011 Nov;26(11):2565-78. doi: 10.1002/jbmr.488. Epub 2011 Sep 13. J Bone Miner Res. 2011. PMID: 21915901 Free PMC article.

5

Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice.

Notini AJ, McManus JF, Moore A, Bouxsein M, Jimenez M, Chiu WS, Glatt V, Kream BE, Handelsman DJ, Morris HA, Zajac JD, Davey RA. Notini AJ, et al. Among authors: kream be. J Bone Miner Res. 2007 Mar;22(3):347-56. doi: 10.1359/jbmr.061117. J Bone Miner Res. 2007. PMID: 17147488 Free article.

6

Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition.

Delahunty KM, Shultz KL, Gronowicz GA, Koczon-Jaremko B, Adamo ML, Horton LG, Lorenzo J, Donahue LR, Ackert-Bicknell C, Kream BE, Beamer WG, Rosen CJ. Delahunty KM, et al. Among authors: kream be. Endocrinology. 2006 Aug;147(8):3915-23. doi: 10.1210/en.2006-0277. Epub 2006 May 4. Endocrinology. 2006. PMID: 16675518

7

Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor.

Chandhoke TK, Huang YF, Liu F, Gronowicz GA, Adams DJ, Harrison JR, Kream BE. Chandhoke TK, et al. Among authors: kream be. Bone. 2008 Jul;43(1):101-109. doi: 10.1016/j.bone.2008.03.012. Epub 2008 Mar 29. Bone. 2008. PMID: 18460422 Free PMC article.

8

CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.

Liu F, Lee SK, Adams DJ, Gronowicz GA, Kream BE. Liu F, et al. Among authors: kream be. Bone. 2007 Apr;40(4):1135-43. doi: 10.1016/j.bone.2006.12.003. Epub 2007 Feb 1. Bone. 2007. PMID: 17275432 Free PMC article.

9

Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.

Yang M, Trettel LB, Adams DJ, Harrison JR, Canalis E, Kream BE. Yang M, et al. Among authors: kream be. Bone. 2010 Sep;47(3):573-82. doi: 10.1016/j.bone.2010.06.002. Epub 2010 Jun 9. Bone. 2010. PMID: 20541046 Free PMC article.

10

Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice.

Gao Q, Zhan P, Alander CB, Kream BE, Hao C, Breyer MD, Pilbeam CC, Raisz LG. Gao Q, et al. Among authors: kream be. Bone. 2009 Jul;45(1):98-103. doi: 10.1016/j.bone.2009.03.667. Epub 2009 Apr 1. Bone. 2009. PMID: 19344793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters